Austin pharma company makes play for 2 new drugs

Austin pharma company makes play for 2 new drugsAustin pharmaceutical group Savara Inc. will be adding a new respiratory drug in its catalogue as the company has announced they have made a deal with Serendrex Pharmaceuticals in Denmark for the company’s assets. Although the full details of the deal are not made public, the acquisition is said to expand Savara’s orphan respiratory drug line which may help cure diseases which currently has no medical treatment. The US Food and Drug Administraiton stated that both Savara and Serendrex will be working on these “orphan drugs” to assist in the research for treating rare conditions that currently plagues 200,000 patients in the country.

Read more about this here: Austin pharma company makes play for 2 new drugs

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top

FREE Report of Available Spaces!

Receive a free list of available spaces custom to your needs complete with lease rates, photos, and floor plans: